LCTX peer analysis
Lineage Cell Therapeutics (LCTX) against its competitors: price, today's move, 1-year return and market value side by side.
LCTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CELU Celularity | $0.62 | -1.75% | -60.06% | $20.09M |
| IPSC Century Therapeutics | $1.46 | -10.98% | 219.71% | $274.21M |
| MESO Mesoblast | $11.90 | -4.42% | -20.24% | $1.52B |
| LCTX Lineage Cell Therapeutics | $0.85 | 7.03% | -57.63% | $201.48M |
- LCTX's peers: CELU (Celularity), IPSC (Century Therapeutics), MESO (Mesoblast).
Updated 2026-11-17 17:46 UTC